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We describe the GALT-Prot database and its related web-based application that
have been developed to collect information about the structural and functional
effects of mutations on the human enzyme galactose-1-phosphate uridyltransferase
(GALT) involved in the genetic disease named galactosemia type I. Besides a list
of missense mutations at gene and protein sequence levels, GALT-Prot reports
the analysis results of mutant GALT structures. In addition to the structural
information about the wild-type enzyme, the database also includes structures of
over 100 single point mutants simulated by means of a computational procedure,
and the analysis to each mutant was made with several bioinformatics programs
in order to investigate the effect of the mutations. The web-based interface allows
querying of the database, and several links are also provided in order to guarantee
a high integration with other resources already present on the web. Moreover, the
architecture of the database and the web application is f lexible and can be easily
adapted to store data related to other proteins with point mutations. GALT-Prot
is freely available at http://bioinformatica.isa.cnr.it/GALT/.
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Introduction
Genetic diseases are caused by single or multiple nu-
cleotide mutations that are reflected at protein se-
quence level as point mutations in most cases (1 ).
Databases for genetic pathologies are generally con-
ceived to show mainly a list of mutations at gene
level and possibly the related amino acid mutation,
with additional information such as clinical features,
associated literature, and so on (2 ). However, less
attention is generally given to the impact of the mu-
tations on the protein tertiary structure; it is assumed
that a mutation will cause negative consequences, but
often we do not know why. The lack of experimen-
tal information on the structural organization of mu-
tated proteins is a relevant problem, which is due to
the evident difficulty to obtain the needed amount of
proteins and to perform experimental structural stud-
ies on dozens or even hundreds of different mutants.
In this context, the availability of data to understand
the effects of the mutations at protein structure level
would be very useful to fill the gap between the ex-
perimental study and the knowledge of the molecular
bases of the pathology.
In this paper, we present a database, GALT-Prot,
for storing analysis results on the structure of the hu-
man enzyme galactose-1-phosphate uridyltransferase
(GALT) (EC 2.7.7.12) and its single point mutants,
with a web application to allow its consultation world-
wide. This enzyme is associated with the genetic
disorder called galactosemia type I (classical galac-
tosemia) (OMIM: 230400), which is caused by more
than 180 sequence variations in the GALT gene, of
which about 150 are missense mutations (3–7 ).
The three-dimensional (3D) structure of this hu-
man enzyme has not yet been obtained by experimen-
tal methods, but it has been created by homology
modeling methods (8 ). On the basis of this model,
we have been able to investigate the position and the
influence of each residue on the structure and on the
dimeric assembly of the enzyme. Moreover, using a
fully automated procedure, we have been able to cre-
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ate the structures of GALT mutants described in lit-
erature, and to analyze their structural features as
well, with the aim of explaining molecular events that
could be related to this pathology (Marabotti et al,
manuscript in preparation).
These analyses may improve the comprehension
of the structural and functional features of the wild-
type enzyme, and the effects of the missense muta-
tions on GALT structure and function. Therefore,
we decided to organize them in a database and to
share them with the widest possible number of peo-
ple via a web-based interface, in an interactive and
up-to-date way. The database is now freely available
at http://bioinformatica.isa.cnr.it/GALT/. To our
knowledge, this is the first database and web resource
for galactosemia that is dedicated to the analysis of
the protein and the effects of the mutations on the
protein structure and function, since other resources
[such as ARUPdb (3 )] are mainly focused on the col-
lection of GALT mutations at genetic level and on the
description of their clinical outcome. The integration
of information stored in “traditional” databases with
those hosted by our database would give more com-
plete and direct information, with a positive impact




GALT-Prot allows storing and disseminating informa-
tion about structural and functional features of hu-
man GALT enzyme, with the possibility of constant
update. Moreover, the architecture of the database
and the web application is flexible and allows storing
data related to other proteins with mutations, with-
out the need of main changes.
The web application is composed of two main sec-
tions, one for the wild-type protein and the other
for mutants. In the first section, users can retrieve
the information about wild-type GALT stored in the
database, all together or focusing the research to one
or more kinds of structural and functional informa-
tion. Filters can be applied to retrieve information
related to one residue by using its sequence number,
or related to a residue type. Information available on
the wild-type protein (Figure 1) includes: the con-
servation score of each residue in the 3D model of
the protein (which starts from residue 21 of the hu-
man GALT sequence), the local secondary structure
context attributed by DSSP software (9 ) in terms of
secondary structure code, ϕ and φ angles, the sol-
vent accessible surface area computed with the aid of
NACCESS software (10 ), both in the monomer and in
the dimeric assembly (a difference between the values
suggests the involvement of the residue in the dimer
interface), the involvement of the residue in H-bonds
detected by means of HBPLUS software (11 ), and the
analysis of enzyme-substrate interactions obtained by
visual inspection of the 3D model of the wild-type
enzyme bound to the substrate. These kinds of in-
formation can help in understanding the role of each
residue in structure, activity and dimeric assembly of
the protein, and, indirectly, what kind of molecular
features would be affected if the selected residue(s)
would be involved in mutations.
In the second section, users can indicate the se-
quence number of a residue involved in mutations, or
select a particular sequence mutation (for example,
from Ala to Ser), provided that it exists. The appli-
cation outputs a table (Figure 2A) that contains in-
formation on original and mutant codons and amino
acids as reported by literature, the conservation score
of the corresponding residue, and the primary litera-
ture reference associated with each mutation. These
references are reported in a page that allows direct
link, when available, to PubMed abstracts. Moreover,
for each mutation a linked web page hosts all infor-
mation obtained on that mutation, in order to ensure
a high flexibility of the application (Figure 2B). In
each web page, it is possible to find an overview of
the mutation with a description of its features derived
from a cross-link to the SwissProt/UniProt database
(12 ). A link allows people to download the PDB
file of the mutant protein, obtained using a Python
script implemented in the MODELLER program (13 )
as described in Materials and Methods. We also re-
port the results of structural analyses performed on
the mutant, with the aim to highlight some draw-
backs of the structure following the introduction of
these mutations and to help people in detecting which
could be the most significant impairments introduced
by each mutation in the structure and function of
GALT enzyme. These analyses are shown together
with the corresponding results obtained for the wild-
type residue in the 3D model of GALT protein, to
help the comparison between the different features.
Additional sections of the web application include
several links to external web sites that provide general
information on classical galactosemia and on GALT
gene or protein stored in scientific or in general
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Figure 1 Example of results of a search for the information about the wild-type protein. The table contains the
analysis results of the protein structure using the tools DSSP, NACCESS and HBPLUS.
resources (including links to GALT gene databases),
and to web sites of patient associations and non-profit
organizations.
Data submission and management
Users can submit information about newly detected
mutations by means of a form. The administrator re-
ceives the information and performs the validation of
the submission, then the structure of the new mutant
is modeled, analyzed and the database is updated by
means of a stand-alone application. When the data
are added, information linked to the particular residue
is retrieved and visualized in the database. At this
point, people submitting the mutations are alerted
that their model is available for analysis. Another
form is provided to contact the database administra-
tor without submitting mutations. At present, it is
not possible to model and analyze the structure in an
interactive way, but we are planning to allow it in the
future.
Materials and Methods
Creation and analysis of mutants
The 3D model of human GALT enzyme (8 ) was
used as a starting point to analyze structural fea-
tures of the wild-type enzyme and to create 107 sin-
gle point mutants related to galactosemia, selected
on the basis of the presence of published references.
Information about the list of gene mutations can
be found in the literature (14 ) and in the pub-
lic database of GALT mutations at genetic level
(GALTdb) developed by Calderon and co-workers
(3 ). Mutants were modeled using a Python script
implemented in the MODELLER program v8.2 (13 )
(http://salilab.org/modeller/wiki/Mutate model).
This script implements a fully automated procedure
that has been developed to model mutations in pro-
tein structures (15 ).
We employed protein structure analysis software
DSSP (9 ), NACCESS (10 ), and HBPLUS (11 ) to
extract information about secondary structure, rela-
tive solvent accessibility, and H-bond patterns, thus
evaluating variations between each mutant and the
wild type. An in-house script was also developed
to predict the presence of salt bridges in the pro-
tein. Moreover, each mutant structure was submit-
ted to two different web servers, PoPMuSiC (16 ) and
DMUTATION (17 ), to predict the mutation-induced
change of protein stability with respect to the wild-
type enzyme. Since the two servers use different cri-
teria to evaluate the impact of mutation on stability,
we decided to consider it reliable only when the re-
sults of both predictors reached a consensus, and the
mutant protein was classified into “more unstable”,
“unchanged” or “more stable”, taking the wild-type
protein as reference. When a consensus between the
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Figure 2 Example of results of a search for the information about the mutant protein. A. The table contains the
name of the mutant, the original and mutant codon and amino acid, and conservation score. B. An example of static
page in which the information about general and structural features and the prediction of stability of the mutant is
shown.
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two methods is not reached, the effect is not deter-
mined.
In addition to these kinds of information, for each
residue an evaluation of its conservation in the whole
GALT family was performed with the AMAS server
based on the algorithm by Livingstone and Barton
(18 ).
System design and development
The data were firstly modeled using an entity-
relationship (ER) diagram (19 ) where some entities
are worth to be noted (Figure 3). The Protein entity,
for example, is introduced to make the final database
capable of storing data not just for the GALT protein.
The Chain entity, a weak entity whose occurrences are
identified by a code and by the corresponding protein,
is used to model amino acid chains. The Analysis en-
tity is again a weak entity identified by the element of
the chain under study, and is specialized into several
entities (H-bonds, DSSP, Monomer, etc). The occur-
rence of the Mutation entity represents a mutation to
be stored. Then, we translated the ER diagram into
a logical model (Figure 4). Since we are interested in
using a classical relational database management sys-
tem, we have to eliminate the generalization; therefore
we eliminated the Analysis entity and just remained
its child entities in order to avoid a lot of null values.
We have also considered the performance of the whole
database, introducing several indexes and some views
to make queries simpler.
To realize the web application, we used Java as the
coding language and employed Struts (20 ), a frame-
work that implements the Model 2 approach (a widely
adopted variant of the Model-View-Controller design
paradigm). Here a Controller servlet acts as a con-
troller for the whole application while the business
logic resides into java beans and other helper classes
(the Model). The presentation layer (the View) is re-
alized using JSP pages and tag libraries. Eclipse (21 )
and Exadel (http://www.exadel.com) are used as de-
velopment tools.
Figure 3 Scheme of the entity-relationship (ER) model.
Figure 4 Scheme of the logical model.
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